[English] 日本語
Yorodumi- EMDB-27039: SARS-CoV-2 S protein mix in complex with Novavax NHP 36057 polycl... -
+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-27039 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | SARS-CoV-2 S protein mix in complex with Novavax NHP 36057 polyclonal Fab | |||||||||
Map data | refined map of SARS-CoV-2 ancestral spike mix with Novavax NHP 36057 fabs (C1 symmetry) | |||||||||
Sample |
| |||||||||
Biological species | Severe acute respiratory syndrome coronavirus 2 / Macaca mulatta (Rhesus monkey) | |||||||||
Method | single particle reconstruction / negative staining / Resolution: 25.0 Å | |||||||||
Authors | Jackson AM / Bangaru S / Ward AB | |||||||||
Funding support | United States, 1 items
| |||||||||
Citation | Journal: Immunity / Year: 2022 Title: Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses. Authors: Jeroen M J Tas / Ja-Hyun Koo / Ying-Cing Lin / Zhenfei Xie / Jon M Steichen / Abigail M Jackson / Blake M Hauser / Xuesong Wang / Christopher A Cottrell / Jonathan L Torres / John E Warner / ...Authors: Jeroen M J Tas / Ja-Hyun Koo / Ying-Cing Lin / Zhenfei Xie / Jon M Steichen / Abigail M Jackson / Blake M Hauser / Xuesong Wang / Christopher A Cottrell / Jonathan L Torres / John E Warner / Kathrin H Kirsch / Stephanie R Weldon / Bettina Groschel / Bartek Nogal / Gabriel Ozorowski / Sandhya Bangaru / Nicole Phelps / Yumiko Adachi / Saman Eskandarzadeh / Michael Kubitz / Dennis R Burton / Daniel Lingwood / Aaron G Schmidt / Usha Nair / Andrew B Ward / William R Schief / Facundo D Batista / Abstract: Vaccines generate high-affinity antibodies by recruiting antigen-specific B cells to germinal centers (GCs), but the mechanisms governing the recruitment to GCs on secondary challenges remain unclear. ...Vaccines generate high-affinity antibodies by recruiting antigen-specific B cells to germinal centers (GCs), but the mechanisms governing the recruitment to GCs on secondary challenges remain unclear. Here, using preclinical SARS-CoV and HIV mouse models, we demonstrated that the antibodies elicited during primary humoral responses shaped the naive B cell recruitment to GCs during secondary exposures. The antibodies from primary responses could either enhance or, conversely, restrict the GC participation of naive B cells: broad-binding, low-affinity, and low-titer antibodies enhanced recruitment, whereas, by contrast, the high titers of high-affinity, mono-epitope-specific antibodies attenuated cognate naive B cell recruitment. Thus, the directionality and intensity of that effect was determined by antibody concentration, affinity, and epitope specificity. Circulating antibodies can, therefore, be important determinants of antigen immunogenicity. Future vaccines may need to overcome-or could, alternatively, leverage-the effects of circulating primary antibodies on subsequent naive B cell recruitment. | |||||||||
History |
|
-Structure visualization
Supplemental images |
---|
-Downloads & links
-EMDB archive
Map data | emd_27039.map.gz | 49.3 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-27039-v30.xml emd-27039.xml | 15 KB 15 KB | Display Display | EMDB header |
Images | emd_27039.png | 18.4 KB | ||
Others | emd_27039_half_map_1.map.gz emd_27039_half_map_2.map.gz | 49.4 MB 49.4 MB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-27039 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-27039 | HTTPS FTP |
-Validation report
Summary document | emd_27039_validation.pdf.gz | 474.7 KB | Display | EMDB validaton report |
---|---|---|---|---|
Full document | emd_27039_full_validation.pdf.gz | 474.3 KB | Display | |
Data in XML | emd_27039_validation.xml.gz | 12.3 KB | Display | |
Data in CIF | emd_27039_validation.cif.gz | 14.4 KB | Display | |
Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-27039 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-27039 | HTTPS FTP |
-Related structure data
Related structure data | C: citing same article (ref.) |
---|
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|
-Map
File | Download / File: emd_27039.map.gz / Format: CCP4 / Size: 64 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | refined map of SARS-CoV-2 ancestral spike mix with Novavax NHP 36057 fabs (C1 symmetry) | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 2.06 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: half map of SARS-CoV-2 ancestral spike mix with...
File | emd_27039_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | half map of SARS-CoV-2 ancestral spike mix with Novavax NHP 36057 fabs (C1 symmetry) | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: half map of SARS-CoV-2 ancestral spike mix with...
File | emd_27039_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | half map of SARS-CoV-2 ancestral spike mix with Novavax NHP 36057 fabs (C1 symmetry) | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Sample components
-Entire : SARS-CoV-2 S protein mix in complex with Novavax NHP 36057 polycl...
Entire | Name: SARS-CoV-2 S protein mix in complex with Novavax NHP 36057 polyclonal Fab |
---|---|
Components |
|
-Supramolecule #1: SARS-CoV-2 S protein mix in complex with Novavax NHP 36057 polycl...
Supramolecule | Name: SARS-CoV-2 S protein mix in complex with Novavax NHP 36057 polyclonal Fab type: complex / Chimera: Yes / ID: 1 / Parent: 0 |
---|
-Supramolecule #2: SARS-CoV-2 S protein
Supramolecule | Name: SARS-CoV-2 S protein / type: complex / Chimera: Yes / ID: 2 / Parent: 1 |
---|---|
Source (natural) | Organism: Severe acute respiratory syndrome coronavirus 2 |
Recombinant expression | Organism: Homo sapiens (human) |
-Supramolecule #3: Novavax NHP 36057 Polyclonal Fab
Supramolecule | Name: Novavax NHP 36057 Polyclonal Fab / type: complex / Chimera: Yes / ID: 3 / Parent: 1 |
---|---|
Source (natural) | Organism: Macaca mulatta (Rhesus monkey) |
Recombinant expression | Organism: Homo sapiens (human) |
-Experimental details
-Structure determination
Method | negative staining |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Buffer | pH: 7.4 |
---|---|
Staining | Type: NEGATIVE / Material: uranyl formate |
-Electron microscopy
Microscope | FEI TECNAI SPIRIT |
---|---|
Image recording | Film or detector model: FEI EAGLE (4k x 4k) / Average electron dose: 50.0 e/Å2 |
Electron beam | Acceleration voltage: 120 kV / Electron source: LAB6 |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 1.0 µm |
Experimental equipment | Model: Tecnai Spirit / Image courtesy: FEI Company |
-Image processing
Startup model | Type of model: PDB ENTRY PDB model - PDB ID: |
---|---|
Final reconstruction | Resolution.type: BY AUTHOR / Resolution: 25.0 Å / Resolution method: FSC 0.5 CUT-OFF / Number images used: 89236 |
Initial angle assignment | Type: OTHER |
Final angle assignment | Type: OTHER |